IL160967A0 - Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome - Google Patents

Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome

Info

Publication number
IL160967A0
IL160967A0 IL16096702A IL16096702A IL160967A0 IL 160967 A0 IL160967 A0 IL 160967A0 IL 16096702 A IL16096702 A IL 16096702A IL 16096702 A IL16096702 A IL 16096702A IL 160967 A0 IL160967 A0 IL 160967A0
Authority
IL
Israel
Prior art keywords
treatment
receptor agonists
acetylcholine receptor
nicotinic acetylcholine
restless legs
Prior art date
Application number
IL16096702A
Other languages
English (en)
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of IL160967A0 publication Critical patent/IL160967A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
IL16096702A 2001-10-31 2002-10-21 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome IL160967A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US33481001P 2001-10-31 2001-10-31
US33585801P 2001-11-26 2001-11-26
PCT/IB2002/004379 WO2003037329A1 (en) 2001-10-31 2002-10-21 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome

Publications (1)

Publication Number Publication Date
IL160967A0 true IL160967A0 (en) 2004-08-31

Family

ID=26989404

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16096702A IL160967A0 (en) 2001-10-31 2002-10-21 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome

Country Status (14)

Country Link
EP (1) EP1439836A1 (ko)
JP (1) JP2005507411A (ko)
KR (1) KR20050038583A (ko)
CN (1) CN1568184A (ko)
BR (1) BR0213696A (ko)
CA (1) CA2460118A1 (ko)
CZ (1) CZ2004524A3 (ko)
HU (1) HUP0401967A2 (ko)
IL (1) IL160967A0 (ko)
MX (1) MXPA04002539A (ko)
PL (1) PL370549A1 (ko)
SK (1) SK1912004A3 (ko)
TW (1) TW200300139A (ko)
WO (1) WO2003037329A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004103372A1 (en) * 2003-05-20 2004-12-02 Pfizer Products Inc. Pharmaceutical compositions of varenicline
MXPA06003043A (es) 2003-09-17 2006-05-31 Xenoport Inc Tratamiento o prevencion del sindrome piernas inquietas utilizando prodrogas de analogos gaba.
EP1934174B1 (en) 2005-10-07 2011-04-06 Exelixis, Inc. Azetidines as mek inhibitors for the treatment of proliferative diseases
US7999006B2 (en) 2006-12-14 2011-08-16 Exelixis, Inc. Methods of using MEK inhibitors
PT3417862T (pt) 2012-07-27 2021-08-06 Neurodyn Life Sciences Inc Biodisponibilidade cerebral da galantamina melhorada através de formulações selecionadas e administração transmucosal de pró-fármacos lipofílicos
JP6272857B2 (ja) * 2012-07-27 2018-01-31 ニューロダイン ライフ サイエンシズ インコーポレイテッドＮｅｕｒｏｄｙｎ Ｌｉｆｅ Ｓｃｉｅｎｃｅｓ Ｉｎｃ． 選ばれた処方物によるガランタミンの向上した脳バイオアベイラビリティおよび親油性プロドラッグの経粘膜投与
MX2015004660A (es) 2012-10-12 2015-08-07 Exelixis Inc Proceso novedoso para la elaboración de compuestos para su uso en el tratamiento del cáncer.
WO2016188932A2 (en) 2015-05-22 2016-12-01 Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Combination compositions and their use in methods for treating obesity and obesity-related disorders
WO2018236957A1 (en) * 2017-06-20 2018-12-27 Nexien Biopharma, Inc. METHOD AND COMPOSITIONS FOR TREATING REST-FREE LEG SYNDROME

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020335A (en) * 1997-02-06 2000-02-01 Pfizer Inc (N-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents
US5977131A (en) * 1997-04-09 1999-11-02 Pfizer Inc. Azaindole-ethylamine derivatives as nicotinic acetylcholine receptor binding agents
US6605610B1 (en) * 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
EP0955301A3 (en) * 1998-04-27 2001-04-18 Pfizer Products Inc. 7-aza-bicyclo[2.2.1]-heptane derivatives, their preparation and use according to their affinity for neuronal nicotinic acetylcholine receptors
CA2330576A1 (en) * 1998-04-29 1999-11-04 Pfizer Products Inc. Substituted benzazocines as nicotine-binding inhibitors

Also Published As

Publication number Publication date
CA2460118A1 (en) 2003-05-08
JP2005507411A (ja) 2005-03-17
SK1912004A3 (en) 2004-09-08
EP1439836A1 (en) 2004-07-28
HUP0401967A2 (hu) 2005-01-28
CZ2004524A3 (cs) 2004-07-14
MXPA04002539A (es) 2004-05-31
CN1568184A (zh) 2005-01-19
PL370549A1 (en) 2005-05-30
TW200300139A (en) 2003-05-16
KR20050038583A (ko) 2005-04-27
BR0213696A (pt) 2004-10-26
WO2003037329A1 (en) 2003-05-08

Similar Documents

Publication Publication Date Title
HUP0101954A3 (en) Use of cabergoline in the production of pharmaceutical compositions for the treatment of restless legs syndrome
ME02324B (me) Alfa-aminoamidni derivati djelotvorni u tretmanu sindroma nemirnih nogu
IL155591A0 (en) New treatments for restless legs syndrome
IL158985A0 (en) Benzoylsulfonamides and sulfonylbenzamidines for use as antitumour agents
NO20022176D0 (no) Absorberende gjenstand og fremgangsmåte for fremstilling av denne
EP1448669A4 (en) POLYIMIDE COPOLYMER AND METHOD FOR THE PRODUCTION THEREOF
EP1347866A4 (en) WOOD PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF
IL160967A0 (en) Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
IL158254A0 (en) Indolinones, substituted in position 6, and their use as kinase inhibitors
DK1307446T3 (da) Perfluoralkylholdige komplekser med sukkerrester, fremgangsmåde til deres fremstilling og deres anvendelse
NO20011580D0 (no) Pulverisert mannitol og fremgangsmåte for dets fremstilling
GB2375956B (en) Chair for infants
GB2372695B (en) Improvements in furniture
EP1487799A4 (en) 9-AMINOACRIDINE DERIVATIVES AND METHOD FOR THE PRODUCTION THEREOF
GB2372248B (en) Kiln furniture
SI1066038T1 (sl) Uporaba kabergolina za zdravljenje sindroma nemirnih nog
HUP0402141A3 (en) Herbicidal composition and process for its use
PL110941U1 (en) Furniture base in particular that for repose-type piece of furniture
GB2362821B (en) Furniture apparatus
GB0211677D0 (en) Retaining apparatus for use in furniture
PL111263U1 (en) Support in particular that for pieces of furniture
GB9926941D0 (en) Feetf for furniture legs
IT1311018B1 (it) Gambo regolabile per mobili e tavoli in particolare.
TW551085U (en) Heat-insulated structure of processing table
TW527880U (en) Simple foldable table for picnic use